Next Article in Journal
Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations
Next Article in Special Issue
Aflibercept Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer: A Single-Institution Real-Life Experience
Previous Article in Journal
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma
 
 
Article

Article Versions Notes

Cancers 2021, 13(9), 2168; https://doi.org/10.3390/cancers13092168
Action Date Notes Link
article pdf uploaded. 30 April 2021 13:08 CEST Version of Record https://www.mdpi.com/2072-6694/13/9/2168/pdf-vor
article supplementary file uploaded. 30 April 2021 13:08 CEST - https://www.mdpi.com/2072-6694/13/9/2168#supplementary
article xml file uploaded 1 May 2021 14:58 CEST Original file -
article xml uploaded. 1 May 2021 14:58 CEST Update https://www.mdpi.com/2072-6694/13/9/2168/xml
article pdf uploaded. 1 May 2021 14:58 CEST Updated version of record https://www.mdpi.com/2072-6694/13/9/2168/pdf
article html file updated 1 May 2021 14:59 CEST Original file -
article html file updated 26 July 2022 17:45 CEST Update https://www.mdpi.com/2072-6694/13/9/2168/html
Back to TopTop